The EPIC Observational Study
Trial ID or NCT#
Status
Purpose
The purpose of this study is to better define risk factors preceding first isolation of Pseudomonas aeruginosa (Pa) from respiratory cultures in cystic fibrosis (CF) lung disease and to better define clinical outcomes associated with acquisition of Pa. This study will also collect and bank DNA samples for current and future studies designed to enhance the understanding of the pathogenesis of CF.
Official Title
Longitudinal Assessment of Risk Factors For and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children With CF
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Colleen Dunn
6507360388
View on ClinicalTrials.gov